Pseudomonas aeruginosa (Schroeter) Migula 拉丁名
BAA-2108 編號
Product categoryBacteria
Product type Drug-resistant bacterium
Strain designation PGO2330 別名
Type strain 模式菌株 No
Genome sequenced strain Yes
Isolation 分離源 source
Sputum sample
Applications 用途 Antimicrobial resistance research
Drug development
Product format 提供形式 Frozen
Storage conditions 保藏條件 -80°C or colder
Preceptrol No
Susceptibility profile
Resistant
Imipenem
Meropenem
Tobramycin
Intermediate
Amikacin
Ciprofloxacin
Doripenem
Susceptible
Aztreonam
Cefepime
Ceftazidime
Ceftazidime-avibactam
Ceftolozane-Tazobactam
Piperacillin-tazobactam
Comments
This isolate was collected from a sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin). The 1995-1996 clinical trial was conducted by a consortium led by Chiron and later acquired by Novartis AG.
Medium 培養(yǎng)基 ATCC Medium 18: Trypticase Soy Agar/Broth
Temperature 培養(yǎng)溫度 37°C
Atmosphere 需氧情況 Aerobic
Handling procedure
Just prior to inoculation place the frozen vial at room temperature to thaw.
Transfer the entire contents of the vial to a tube of #18 broth (5 to 6 mL).
Use several drops of the cell suspension to inoculate a #18 agar slant and/or plate. Additional #18 broth tubes may be inoculated by transferring 0.5 mL of the primary tube to each addition broth tube.
Incubate the tubes and plate at 37°C for 24 hours.
Depositors
Chiron/Novartis
Type of isolate Human
